Journal of the Korea Academia-Industrial cooperation Society (한국산학기술학회논문지)

The Korea Academia-Industrial cooperation Society (한국산학기술학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of the signal intensity of magnetic resonance angiography in accordance with the dilution rate of the contrast agent

조영제 희석률에 따른 조영증강 자기공명혈관조영검사의 신호강도 평가

  • 최관우 (서울아산병원 영상의학과) ;
  • 서성미 (서울아산병원 영상의학과) ;
  • 손순룡 (서울아산병원 영상의학과)
  • Received : 2014.04.25
  • Accepted : 2014.08.07
  • Published : 2014.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Dilution of the contrast agent by analyzing the change in the signal intensity during MR angiography in accordance with the viscosity and osmotic pressure minimizes the side effects, and improves the image quality. The contrast agent molarity changes by the dilution of the contrast agent in the blood, as it is injected, which leads to a change in signal intensity. Based on this principle, a phantom was prepared and experiments were performed. After the phantom experiment, a clinical experiment was conducted using the results of the phantom experiment. From November 2013 to January 2014, a group of patients were classified into diluted contrast agent (30 persons) and undiluted (30 persons), and the signal intensity of the cerebral vessels was compared. The signal intensity of the phantom according to the molarity of the contrast agent increased sharply from 0.0125 mmol, reached a peak at 20 mmol, and achieved equilibrium from 200 mmol. Based on the study results, the signal intensity of the blood vessels in the brain through were compared in a clinical experiment. All the brain vessels in the imaging range with diluting a high content of the gadolinium contrast agent showed high signal intensity. This result supports the phantom experiment and means that using the 500mmol diluted contrast agent is better than using 1000mmol undiluted contrast agent because it is easier to approach the 20mmol level needed to achieve the highest signal intensity. This study has significance in that it can minimize the high viscosity and osmotic pressure, which can cause side effects and improve the image quality using the method of the dilution rate.

조영제의 희석률 변화에 따른 신호강도를 분석하여 조영증강 자기공명혈관조영검사 시 점도와 삼투압에 따른 부작용을 최소화하고 신호강도를 높여 영상의 질을 향상시키고자 하였다. 연구방법은 조영제가 혈관에 주입되면 혈액과 희석되어 mol 농도가 변화되고, 그에 따라 신호강도의 변화를 일으킴에 착안하여 phantom을 제작하였다. phantom 결과를 바탕으로 임상실험은 2013년 11월부터 2014년 1월까지 조영제를 희석한 군(30명)과 희석하지 않은 군(30명)으로 구분하여 뇌혈관의 신호강도를 비교하였다. 연구결과, 조영제 mol 농도 변화에 따른 phantom의 신호강도는 0.0125mmol부터 급격히 증가하다 20mmol에서 최고점을 이룬 후 200mmol부터 평형을 이루었다. 임상실험에서도 조영제를 희석하여 검사한 영상의 신호강도가 모두 높게 나타나, 1000mmol 조영제 사용에 비해 500mmol로 희석하여 사용함이 최고점인 20mmol에 근접하여 우수함을 알 수 있었다. 결론적으로 조영제를 희석하여 사용함으로써 점도와 삼투압을 저하시키고, 영상의 질을 향상시킬 수 있었으므로 임상적용의 유용성이 높다고 할 수 있다.

Keywords

References

  1. YS Ji, BJ Lee, "Usefulness of 3-dimensional gadoliniumenhanced MR angiography for the evaluation of pedal artery: comparison with digital subtraction angiography", J Korean Radiol Soc, Vol. 24, No. 2, pp.23-28, 2001.
  2. BJ Park, MG Kim, SI Suh, SJ Hong, KR Cho, BK Seo, KY Lee, NJ Lee, JH Kim, "Test Bolus Examination in Three-Dimensional Contrast-Enhanced MR Angiography of the Carotid Artery", Journal of the Korean Radiological Society, Vol. 44, No. 3, pp.317-323, 2001. https://doi.org/10.3348/jkrs.2001.44.3.317
  3. Busse H, Schmitgen A, Trantakis C, Schober R, Kahn T, Moche M, "Advanced approach for intraoperative MRI guidance and potential benefit for neurosurgical applications", Journal of Magnetic Resonance Imaging, Vol. 24, No. 1, pp.140-151, 2006. DOI: http://dx.doi.org/10.1002/jmri.20597
  4. WC Huh, "Synthesis of Uniform and Size Controlled Ultrasmall Lanthanide Oxide Nanoparticles for MR Agent Contrast", The graduate school, Kyungpook National university, pp.1-29, 2013.
  5. JH Choi, SM Lim, Y Kim, "Comparison of 3d tof mra with contrast enhanced mra in intracranial atherosclerotic occlusive disease", Journal of the Korean Society of Radiology, Vol. 64, No. 3, pp.203-211, 2011. https://doi.org/10.3348/jksr.2011.64.3.203
  6. SY Kim, YK Kim, SM Yoon, KH Yoo, JS Lim, "Using Keyhole and SENSE Technique 4D (time-resolved) MRA", Journal of The Korean Society of MR Technology, Vol. 18, pp.244-252, 2005.
  7. KW Choi, SY Son, TH Kim, MS Han, JH Lee, JW Min, "Usefulness of contrast agent involving high gadolium content for myocardial viability assessment", Journal of the Korea Academia-Industrial cooperation Society, Vol. 14, No. 3, pp.1294-1300, 2013. DOI: http://dx.doi.org/10.5762/KAIS.2013.14.3.1294
  8. Tombach B, Reimer P, Prumer B, Allkemper T, Bremer C, Muhler A, Heindel W, "Does a higher concentration of gadolinium chelates improve first-pass cardiac signal changes?", Journal of Magnetic Resonance Imaging, Vol. 10, No. 5, pp.806-812, 1999. DOI:http://dx.doi.org/10.1002/(SICI)1522-2586(199911) 10:5<806::AID-JMRI27>3.0.CO;2-0
  9. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E, "Magnetic Resonance Perfusion Measurements for the Noninvasive Detection of Coronary Artery Disease", Circulation, Vol. 108, pp.432-437, 2003. DOI: http://dx.doi.org/10.1161/01.CIR.0000080915.35024.A9
  10. Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelman RR, "First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease", Journal of the American Clollege of Cardiology, Vol. 18, No. 4, pp.956-965, 1991. DOI: http://dx.doi.org/10.1016/0735-1097(91)90754-W
  11. Henrik ST, Sameh KM, Torsten A, Marie-France B, Michele B, Georg B, Olivier C, Peter L, Gertraud HP, Peter R, Fulvio S, Aart M, Judith AW, "Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines", European Society of Radiology, Vol. 23, No. 2, pp.307-318, 2013. DOI: http://dx.doi.org/10.1007/s00330-012-2597-9
  12. Korean Society of Magnetic Resonance in Medicine, Magnetic Resonance Imaging, Korea, Ilchokak, 2008.
  13. YH Lee, "Research for pharmacokinetic analysis about MRI nano-contrast using rat brain tumor model", The graduate school, Yonsei National University, pp.1-38, 2011.
  14. SY Son, YS Kim, KW Choi, SM Seo, JW Min, BG Yoo, JS Lee, "A study of contrast agent peak time using biomechanics factors experimental contrast medium infusion test using at contrast enhanced magnetic resonance angiography", Journal of the Korea Academia-Industrial cooperation Society, Vol. 14, No. 2, pp.786-792, 2013. DOI: http://dx.doi.org/10.5762/KAIS.2013.14.2.786
  15. SJ Bae, CH Lim, BR Park, WJ Shin, JS Kim, "The Value of Comparison with Four Dimension Time Resolved Imaging of Contrast Kinetics(TRICKS) MRA by Time of Flight(TOF) MRA", The Journal of the Korea Contents Association, Vol. 10, No. 3, pp.215-221, 2009. DOI: http://dx.doi.org/10.5392/JKCA.2010.10.3.215
  16. Peldschus K, Hamdorf M, Robert P, Port M, Adam G, Herborn CU, "Comparison of the high relaxivity Gd chelates P1152 and Gd-BOPTA for contrast enhanced MR angiography in rabbits at 1.5 Tesla and 3.0 Tesla", Journal of Magnetic Resonance Imaging, Vol. 32, No. 2, pp.459-465, 2011. DOI: http://dx.doi.org/10.1002/jmri.22261
  17. A.Willinek W, Schild HH, "Clinical advantages of 3.0T MRI over 1.5T". European Society of Radiology, Vol. 65, No. 1, pp.2-14, 2008. DOI: http://dx.doi.org/10.1016/j.ejrad.2007.11.006
  18. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC, "Breath-hold single-dose gadoliniumenhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector", Journal of Radiological Society of North America, Vol. 201, No. 3, pp.705-710, 1996.
  19. Mathias G, Tomas CL, Christoph UH, Jorg FD, MBA, Silke B, Stefan G, Ruehm, "0.5 M Gd chelate (Magnevist(R)) versus 1.0 M Gd chelate (Gadovist(R)): Dose-independent effect on image quality of pelvic three-dimensional MR-angiography", Journal of Magnetic Resonance Imaging, Vol. 14, No. 5, pp.602-607, 2001. DOI: http://dx.doi.org/10.1002/jmri.1225
  20. Haneder S, Attenberger1 U, Schonberg SO,Loewe C, Garcia JA, Michaely HJ, Mannheim DE, Vienna AT, Santander ES, "Intra-individual efficacy evaluation of Dotarem(R)-enhanced MRA compared to Gadovist(R)-enhanced MRA in the diagnosis of clinically significant abdominal or lower limb arterial diseases", European Congress of Radiology, pp.1002-1016, 2010.
  21. Klumpp BD, Sandstede J, Lodemann KP, Seeger A, Hoevelborn T, Fenchel M, et al, "Intraindividual comparison of myocardial delayed enhancement MR imaging using gadobenate dimeglumine at 1.5 T and 3 T", European radiology, pp.1124-1131, 2009. DOI: http://dx.doi.org/10.1007/s00330-008-1248-7